These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7985153)

  • 21. [Bioavailability of 3 theophylline delayed-release preparations. Comparison of theophylline concentrations in the serum and saliva in the steady state].
    Bochsler HP; Meyer UA
    Schweiz Med Wochenschr; 1982 Nov; 112(47):1702-10. PubMed ID: 7178872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reliability of salivary theophylline in monitoring the treatment for apnoea of prematurity.
    Chereches-Panta P; Nanulescu MV; Culea M; Palibroda N
    J Perinatol; 2007 Nov; 27(11):709-12. PubMed ID: 17717520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salivary theophylline monitoring in asthmatic children.
    Orłowski L; Paczkowski D; Podleśny J
    Pol J Pharmacol Pharm; 1987; 39(2):173-6. PubMed ID: 3432165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Saliva-serum theophylline concentrations: substantial intrapatient and interpatient variation in predicting serum concentrations.
    Uden DL; Miller KW; Strand LM; Johnson PB; Zaske DE
    Ther Drug Monit; 1981; 3(2):143-50. PubMed ID: 7268827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of the paraxanthine/caffeine ratio in the saliva of patients with liver cirrhosis].
    Perlík F; Pucelíková T; Slanar O
    Cas Lek Cesk; 2001 Feb; 140(2):51-3. PubMed ID: 11262908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single dose study of the bioequivalence of two sustained-release theophylline formulations.
    Contreras J; Pérez N; González R; Ontivero E; López M
    Arzneimittelforschung; 1998 Mar; 48(3):259-62. PubMed ID: 9553683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative monitoring of oral theophylline treatment in blood serum, saliva, and nasal mucus.
    Henkin RI
    Ther Drug Monit; 2012 Apr; 34(2):217-21. PubMed ID: 22377744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation].
    Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
    Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Application of theophylline as an inhalant (author's transl)].
    Kandt D; Sehrt I; Iwainsky H
    Z Erkr Atmungsorgane; 1981 May; 157(2):152-9. PubMed ID: 7314689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Theophylline-retard preparations: relation between drug liberation in vitro and their behavior in the human body].
    Beerbaum H; Kulpe K; Seidel KH; Zand G; Nussbücker B; Wilke A; Rentsch E; Wiesner B; Iwainsky H
    Pharmazie; 1988 May; 43(5):325-9. PubMed ID: 3174809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissolution of theophylline from sustained-release dosage forms and correlation with saliva bioavailability parameters.
    Chung BH; Shim CK
    J Pharm Sci; 1987 Oct; 76(10):784-7. PubMed ID: 3430341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intersubject variability of serum theophylline concentration after single dose of uncoated controlled release theophylline tablet administration in asthmatic patients.
    Raj NS; Guleria R; Misra A; Pande JN
    Indian J Chest Dis Allied Sci; 1997; 39(3):143-7. PubMed ID: 9357147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Importance of salivary levels of theophylline in monitoring pediatric asthmatic patients].
    Plaza AM; Farré C; Giner MT; Jiménez CV; Sierra JI
    An Esp Pediatr; 1984 Aug; 21(2):101-6. PubMed ID: 6497187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic drug monitoring of theophylline in the serum and saliva].
    Georgiev O; Marinov Kh; Svinarov D; Noneva D
    Vutr Boles; 1989; 28(4):42-5. PubMed ID: 2596100
    [No Abstract]   [Full Text] [Related]  

  • 35. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of isradipine on theophylline pharmacokinetics in healthy volunteers.
    Perreault MM; Kazierad DJ; Wilton JH; Izzo JL
    Pharmacotherapy; 1993; 13(2):149-53. PubMed ID: 8469622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of an ultralong sustained-release theophylline formulation when given twice daily in elderly patients with chronic obstructive pulmonary disease: monitoring implications.
    Armijo JA; Sánchez BM; Peralta FG; González-Ruiz M; Cuadrado A; Verdejo A; Cos MA; Arjona R
    Biopharm Drug Dispos; 2003 May; 24(4):165-71. PubMed ID: 12698500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The clinical pharmacology of a new Soviet preparation theopek].
    Kukes VG; Tsoĭ AN; Stefadu EG; Gneushev ET; Kniazev RP; Gavrilenko LN
    Ter Arkh; 1990; 62(1):67-70. PubMed ID: 2333622
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evaluation of Euphylline-retard based on the measurement of theophylline concentration in the blood serum and spirometric parameters].
    Pietruszewska E; Droszcz W; Wrońska J; Kowalski J
    Pneumonol Pol; 1981 Nov; 49(11):783-9. PubMed ID: 7342049
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of passively absorbed saliva for determination of oral slow-release theophylline bioavailability in children.
    Vaughan LM; Milavetz G; Weinberger MM; Smith GD; Merrick JG
    Drug Intell Clin Pharm; 1988 Sep; 22(9):684-7. PubMed ID: 3215109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.